Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Waldenstrom Macroglobulinaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07231952
What this trial is testing

Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

Who this might be right for
Waldenstrom MacroglobulinemiaLymphoplasmacytic Lymphoma
Memorial Sloan Kettering Cancer Center 40
Early research (Phase 1)Study completedNCT03410901
What this trial is testing

TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas

Who this might be right for
B-Cell Non-Hodgkin LymphomaGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+5 more
Ronald Levy 14
Testing effectiveness (Phase 2)Study completedNCT01474681
What this trial is testing

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

Who this might be right for
Acute Myelocytic LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Novartis Pharmaceuticals 27
Not applicableLooking for participantsNCT07160270
What this trial is testing

This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process

Who this might be right for
Waldenstrom MacroglobulinaemiaPeripheral Neuropathies
Rigshospitalet, Denmark 90
Not applicableLooking for participantsNCT06550427
What this trial is testing

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

Who this might be right for
LymphomaHodgkin LymphomaT-cell Lymphoma+1 more
National Taiwan University Hospital 200
Testing effectiveness (Phase 2)Study completedNCT03133221
What this trial is testing

1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation

Who this might be right for
Non Hodgkin LymphomaFollicular LymphomaIndolent Lymphoma+6 more
University of Maryland, Baltimore 17
Testing effectiveness (Phase 2)WithdrawnNCT01163201
What this trial is testing

T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+14 more
Masonic Cancer Center, University of Minnesota
Early research (Phase 1)Looking for participantsNCT06544265
What this trial is testing

SynKIR-310 for Relapsed/Refractory B-NHL

Who this might be right for
B Cell LymphomaNHL, AdultMantle Cell Lymphoma+23 more
Verismo Therapeutics 36
Testing effectiveness (Phase 2)Looking for participantsNCT07249905
What this trial is testing

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Who this might be right for
LymphomaWaldenström Macroglobulinemia (WM)DLBCL - Diffuse Large B Cell Lymphoma+5 more
ModeX Therapeutics, An OPKO Health Company 180
Large-scale testing (Phase 3)UnknownNCT02991638
What this trial is testing

Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers

Who this might be right for
Chronic Lymphocytic LeukemiaIndolent B-cell LymphomasChronic Hepatitis B+4 more
The University of Hong Kong 62
Early research (Phase 1)Study completedNCT01805375
What this trial is testing

A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies

Who this might be right for
Indolent B-cell LymphomaChronic Lymphocytic LeukaemiaWaldenström Macroglobulinaemia
Cancer Research UK 28
Early research (Phase 1)Study completedNCT04488354
What this trial is testing

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

Who this might be right for
Relapsed/Refractory B-cell LymphomasDiffuse Large B-Cell Lymphoma (DLBCL)Follicular Lymphoma (FL)+9 more
Calibr, a division of Scripps Research 16
Testing effectiveness (Phase 2)Study completedNCT02722668
What this trial is testing

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia/Lymphoma+22 more
Masonic Cancer Center, University of Minnesota 15
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Testing effectiveness (Phase 2)Looking for participantsNCT03314974
What this trial is testing

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more
Masonic Cancer Center, University of Minnesota 300
Not applicableLooking for participantsNCT06860880
What this trial is testing

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

Who this might be right for
Indolent LymphomasLymphomaChronic Lymphocytic Leukemia+6 more
UNC Lineberger Comprehensive Cancer Center 40
Early research (Phase 1)Looking for participantsNCT06340737
What this trial is testing

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

Who this might be right for
Follicular LymphomaMantle Cell LymphomaHairy Cell Leukemia+5 more
Stanford University 148
Testing effectiveness (Phase 2)Looking for participantsNCT04728893
What this trial is testing

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Who this might be right for
Hematologic MalignanciesWaldenstroms MacroglobulinaemiaNon-Hodgkins Lymphoma+1 more
Merck Sharp & Dohme LLC 490
Testing effectiveness (Phase 2)Study completedNCT03015896
What this trial is testing

Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Who this might be right for
Grade 3a Follicular LymphomaRecurrent Burkitt LymphomaRecurrent Diffuse Large B-Cell Lymphoma+12 more
David Bond, MD 36
Testing effectiveness (Phase 2)Study completedNCT04191187
What this trial is testing

Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBiphenotypic Acute Leukemia+15 more
H. Lee Moffitt Cancer Center and Research Institute 34
Next Page